Tempo Therapeutics
Tempo Therapeutics is a pioneering clinical-stage biotechnology company focused on tissue engineering and regenerative medicine. Utilizing its proprietary MAP technology, the company aims to develop synthetic biomaterials for surgical reconstruction and therapeutic regenerative applications, with a mission to harness immunomodulation and material science to transform medical technology and improve patient outcomes.
Industries
Nr. of Employees
small (1-50)
Products
Flowable porous tissue scaffold for surgical soft-tissue regeneration (lead clinical candidate)
A flowable, injectable porous scaffold designed to integrate with host tissue, promote vascularized tissue regrowth, and reduce scar formation at complex surgical resection sites.
Porous scaffold formulation for incision site reinforcement (development candidate)
Synthetic porous scaffold intended to reinforce fascial incision sites and improve mechanical strength during healing.
Flowable porous tissue scaffold for surgical soft-tissue regeneration (lead clinical candidate)
A flowable, injectable porous scaffold designed to integrate with host tissue, promote vascularized tissue regrowth, and reduce scar formation at complex surgical resection sites.
Porous scaffold formulation for incision site reinforcement (development candidate)
Synthetic porous scaffold intended to reinforce fascial incision sites and improve mechanical strength during healing.
Services
Collaborative translational R&D partnerships
Partnerships with academic labs and industry partners to develop and translate porous scaffold biomaterials into preclinical and clinical applications.
Technology transfer and contract manufacturing support
Support for transferring biomaterial production processes to contract manufacturing organizations, including process optimization and validation activities.
Collaborative translational R&D partnerships
Partnerships with academic labs and industry partners to develop and translate porous scaffold biomaterials into preclinical and clinical applications.
Technology transfer and contract manufacturing support
Support for transferring biomaterial production processes to contract manufacturing organizations, including process optimization and validation activities.
Expertise Areas
- Tissue engineering and regenerative medicine
- Biomaterials development and formulation
- Preclinical translational research (small and large animal models)
- Early-phase clinical trial management
Key Technologies
- Microporous injectable hydrogel scaffold platforms
- Hydrogel microsphere fabrication and chemical annealing
- Lyophilization and reconstitution of particulate biomaterials
- Controlled-release biomaterial formulations